Concept:
Chronic Liver Disease (CLD) in pediatric patients is broadly categorized into compensated and decompensated stages based on objective evidence of synthetic dysfunction, portal hypertension, and neuropsychiatric complications.
Explanation:
• Compensated chronic liver disease refers to cirrhosis or advanced fibrosis where the functional synthetic reserve of the liver remains adequately preserved without clinical hallmarks of end-stage failure (INR remains near normal, no ascites, no gastrointestinal variceal hemorrhage, and no hepatic encephalopathy).
• Decompensated chronic liver disease is defined by the development of overt clinical complications reflecting synthetic failure or severe portal hypertension, including coagulopathy (INR $\ge 1.5$ not corrected by parenteral vitamin K), ascites, jaundice (hyperbilirubinemia), variceal bleeding, or hepatic encephalopathy.
• An INR of 2.0 in a child with known chronic liver disease indicates significant loss of hepatic synthetic capacity for vitamin K-dependent coagulation factors (Factors II, VII, IX, X), which formally classifies the patient's liver status as decompensated.
• Hepatic encephalopathy is not mandatory to label a patient as decompensated; the presence of significant coagulopathy, clinically evident ascites, or variceal bleeding alone is sufficient for this classification.
• Acute liver failure (ALF) is excluded because this child has pre-existing chronic liver disease, whereas ALF requires an acute hepatic insult without underlying chronic liver disease.
Final Answer:
The presence of significant synthetic dysfunction (INR = 2.0) in a patient with chronic liver disease categorizes the condition as decompensated chronic liver disease.